These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1827618)

  • 1. Modulative effects of cell adhesion peptide (Arg-Gly-Asp-Ser) on the aggregation of stimulated platelets from ophthalmic patients.
    Babizhayev MA; Mucha AI
    Clin Chim Acta; 1991 Feb; 196(2-3):77-85. PubMed ID: 1827618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1988 Jan; 71(1):132-6. PubMed ID: 3334894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation by collagen is increased in retinal vein occlusion.
    Leoncini G; Bruzzese D; Signorello MG; Armani U; Piana A; Ghiglione D; Camicione P
    Thromb Haemost; 2007 Feb; 97(2):218-27. PubMed ID: 17264950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
    Ugen KE; Mahalingam M; Klein PA; Kao KJ
    J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
    Adelman B; Gennings C; Strony J; Hanners E
    Circ Res; 1990 Oct; 67(4):941-7. PubMed ID: 2208617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Arg-Gly-Asp-Ser (RGDS) peptide on ADP-induced signal transduction of activated rat platelet].
    Yao XH; Wang PY; Pang YZ; Su JY; Tang CS
    Sheng Li Xue Bao; 1998 Apr; 50(2):188-92. PubMed ID: 11324534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activities of synthetic polypeptides containing a repetitive core sequence (Arg-Gly-Asp) of cell adhesion molecules.
    Saiki I; Iida J; Azuma I; Nishi N; Matsuno K
    Int J Biol Macromol; 1989 Feb; 11(1):23-5. PubMed ID: 2489054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adequacy of prescribing the disaggregants in vascular pathology of the eye fundus and in primary open-angle glaucoma].
    Mukha AI
    Vestn Oftalmol; 2005; 121(1):30-3. PubMed ID: 15759845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.